Absence of FLICE-inhibitory protein is a novel independent prognostic marker for very short survival in pancreatic ductal adenocarcinoma

Pancreas

Volumn 42, Issue 7, 2013, Pages 1114-1119

  Schmid, Sandra J ^a   Glatzel, Marie Charlotte ^a   Welke, Claudia ^a   Kornmann, Marko ^a   Kleger, Alexander ^a   Barth, Thomas F E ^a   Fulda, Simone ^b   Lennerz, Jochen K ^a   Möller, Peter ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

biomarker; c FLIP; COX 2; pancreatic cancer; prognostic biomarker

Indexed keywords

CYCLOOXYGENASE 2; FLICE INHIBITORY PROTEIN; KI 67 ANTIGEN;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; COHORT STUDIES; CYCLOOXYGENASE 2; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885177559     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31829655ed     Document Type: Article

References (24)

1. Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet. 2004;363(9414):1049-1057. (Pubitemid 38410779)
2. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2(12):897-909. (Pubitemid 37328891)
3. Fulda S. Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. J Cell Mol Med. 2009;13(7):1221-1227.
4. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407(6805):770-776.
5. Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 2008;19(3-4):325-331.
6. Kataoka T. The caspase-8 modulator c-FLIP. Crit Rev Immunol. 2005;25(1):31-58. (Pubitemid 40733355)
7. Safa AR, Day TW, Wu CH. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Targets. 2008;8(1):37-46. (Pubitemid 351237908)
8. Chang DW, Xing Z, Pan Y, et al. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 2002;21(14):3704-3714. (Pubitemid 34787044)
9. Feoktistova M, Geserick P, Kellert B, et al. cIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell. 2011;43(3):449-463.
10. Wang P, Zhang J, Bellail A, et al. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Cell Signal. 2007;19(11):2237-2246. (Pubitemid 47361680)
11. Haag C, Stadel D, Zhou S, et al. Identification of c-FLIP(L) and c-FLIP (S) as critical regulators of death receptorYinduced apoptosis in pancreatic cancer cells. Gut. 2011;60(2):225-237.
12. Matsubayashi H, Infante JR, Winter J, et al. Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer. Cancer Biol Ther. 2007;6(10):1569-1575. (Pubitemid 351590328)
13. Juuti A, Louhimo J, Nordling S, et al. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer. J Clin Pathol. 2006;59(4):382-386.
14. Hermanova M, Karasek P, Tomasek J, et al. Comparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancer. World J Gastroenterol. 2010;16(15):1879-1884.
15. Campani D, Esposito I, Boggi U, et al. Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol. 2001;194(4):444-450. (Pubitemid 32782669)
16. Skalicky DA, Kench JG, Segara D, et al. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1941-1947. (Pubitemid 44664272)
17. Kawesha A, Ghaneh P, Andren-Sandberg A, et al. K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma. Int J Cancer. 2000;89(6):469-474.
18. Krueger A, Schmitz I, Baumann S, et al. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem. 2001;276(23):20633-20640.
19. Tian F, Lu JJ, Wang L, et al. Expression of c-FLIP in malignant melanoma, and its relationship with the clinicopathological features of the disease. Clin Exp Dermatol. 2012;37(3): 259-265.
20. Bullani RR, Huard B, Viard-Leveugle I, et al. Selective expression of FLIP in malignant melanocytic skin lesions. J Invest Dermatol. 2001;117(2):360-364. (Pubitemid 34205723)
21. Duiker EW, van der Zee AG, de Graeff P, et al. The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer. Gynecol Oncol. 2010;116(3):549-555.
22. Markovic O, Marisavljevic D, Cemerikic V, et al. Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL). Eur J Haematol. 2011;86(3):246-255.
23. McLornan DP, Barrett HL, Cummins R, et al. Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer. Clin Cancer Res. 2010;16(13):3442-3451.
24. Ryu BK, Lee MG, Chi SG, et al. Increased expression of cFLIP(L) in colonic adenocarcinoma. J Pathol. 2001;194(1):15-19.